Clear Point Advisors Inc. Enzo Biochem Inc Transaction History
Clear Point Advisors Inc.
- $122 Billion
- Q1 2024
A detailed history of Clear Point Advisors Inc. transactions in Enzo Biochem Inc stock. As of the latest transaction made, Clear Point Advisors Inc. holds 120 shares of ENZ stock, worth $136. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120
Previous 120
-0.0%
Holding current value
$136
Previous $167,000
8.98%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ENZ
# of Institutions
45Shares Held
16.6MCall Options Held
0Put Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$5.9 Million4.52% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.44MShares$2.78 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$2.14 Million0.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$1.69 Million3.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$1.52 Million9.62% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $55.5M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...